News 
Market Data 
Discover
Replies to post #639877 on NorthWest Biotherapeutics Inc (NWBO)
November 2021: The respected National Labor Secretary had seizures and was taken to a hospital where DCVax-l was likely not being utilized.
December 2021: Had Surgery and was diagnosed with GBM. The tumor was likely not frozen.
Next Margaret had radiation along with Merck’s chemotherapy Temodar (or possibly a generic).
Temodar left Margaret with an infection and her kidneys were not able to process the chemotherapy successfully. Temodar might end up killing her if continued.
Margaret had means to try something else privately, unfortunately she and her care team selected Bristol Myers’s Opdivo (now considered a mono therapeutic failure against GBM by their own company) and Genentech’s Avastin (never proven to extend survival, only temporarily gives false reading tumor is disappearing because it is anti angiogenic).
Her care providers also sent her to Germany for hyperthermia treatments, unfortunately the above therapies in those combinations likely do not allow her immune system to benefit from hyperthermia.
Her sister said there were no other treatments. Which is likely true, because if DCVax-l could not be used if tumor was not properly preserved or no longer met new definition of GBM, it was not an option — unfortunately.
In these types of cases, Dr. Mulholland is correct that it may take years to get an effective treatment, because, for instance, DCVax-Direct (which doesn’t need tumor preservation), and, thanks to you and other parasites, has lacked the funding to move into the next phase of trials.
June 2023: Margaret died 18 months after her diagnosis. (Probably 16 months after Chemotherapy began)
